Lisondra, Novelyn .
HRN: 22-13-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2022
AMPICILLIN 250MG (VIAL)
11/03/2022
11/09/2022
IVT
100mg
Q12
Potentially Septic Newborn
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes